Epidemiological, Clinical and Histopathological prognostic factors in Advanced Oral Squamous Cell Carcinoma treated with Surgery followed by Radiotherapy: A Retrospective Observational study

Not Applicable

• Conditions: Health Condition 1: null- PATIENTS OF ADVANCED ORAL SQUAMOUS CELL CARCINOMA

• Registration Number: CTRI/2013/07/003855
• Lead Sponsor: MAX SUPERSPECIALTY HOSPITA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

. Patients of any age.

. Sex: both males and females

. Histological biopsy confirming Squamous Cell Carcinoma of the Oral cavity (tongue, gingiva, buccal mucosa, floor of mouth, palate, and retro molar region)

. Clinical stage III/IVA (T1-2, N1-2, M0 or T3-4, N0-2, M0, AJCC 2006) with resectable lesions.

• Adequate hematologic function: white blood cell >3,000/mm3, hemoglobin >8g/L, platelet count >80,000/mm3.

Exclusion Criteria

. Patients with distant metastatic disease and other cancers

• Previous radiotherapy, surgery or chemotherapy done other than Max

• Other previous malignancies within last 5 years

• Another histological type of tumour or a tumour not involving the oral cavity,

• Recurrent tumour after previous treatment.

• Patients with inadequate follow-up

• Patients who have undergone for initial RT

Study & Design

• Study Type: Observational
• Study Design: Not specified